$5.930
-0.040 (-0.67%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
Loading chart…
该买入 STLN 股票吗？
Starling Oncology, Inc. is not a good buy right now due to its negative fundamentals and recent performance. The current price is $6.17, and the forward P/E ratio is 0, indicating no expected earnings growth. Additionally, the stock has seen a 5-day change of -4.56%, suggesting a downward trend. The primary risk is the negative P/E ratio of -17.80, which indicates the company is currently unprofitable.
STLN 股价于 Friday 收于 $5.93，此前下跌 -0.67%
(STLN) last closed at $5.93, losing -0.67%. These facts feed the 1-day and 1-week STLN price prediction above.
预测驱动因素
STLN（STLN）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Positive
Bullish
STLN 季节性分析
Loading chart…
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。